Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02973139 · ClinicalTrials.gov registry record · NA
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02973139 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 32 participants.
The verdict
NCT02973139, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant Deoxyribonuclease (DNase) for the management of empyema or complex parapneumonic effusion (CPPE) in adults.
Interventions
- OTHER Medical Thoracoscopy
- OTHER Fibrinolytic Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-07-14 |
| Est. Completion | 2019-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02973139
The ClinicalTrials.gov registry entry for NCT02973139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medical Thoracoscopy is the first listed.
NCT02973139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02973139 about?
NCT02973139 is a clinical study titled "Fibrinolysis Compared to Thoracoscopy for Pleural Infection". The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant Deoxyribonuclease (DNase) for the management...
What is the current status of trial NCT02973139?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-07-14. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT02973139?
The interventions under investigation include: Medical Thoracoscopy (OTHER), Fibrinolytic Group (OTHER).
Who is sponsoring clinical trial NCT02973139?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.